04.04.24 -- Beyond (And Better Than) mRNA: T Cell Vaccines

The ASTM E55 Cleaning Team, in collaboration with F04 Medical Device Committee members, felt that the commonly used three-level criticality system was inadequate. This article shares how science-based criticality levels were derived, the meaning of each level, and how they can be used.

The combination of unique and proven plasmids, fast process development, and automated downstream analysis ensures rapid progression from gene to optimized, high-titer fermentation process.

Selecting the right pDNA supplier is a critical decision that can significantly impact the success of your project or research. Consider these 10 key factors to help you make an informed choice.

Multidrug-resistant bacteria are rendering antibiotics ineffective. Review preclinical results of a potent macrocycle derivative and why collaboration is crucial to transition discoveries into treatments.

ICH Q14 provides comprehensive guidance on analytical procedure development, offering an invaluable framework for ensuring the development of regulatorily compliant analytical procedures.

Discover a protein L affinity chromatography resin that is well suited for use in biomanufacturing and offers increased binding capacities compared to other resins.

Drug developers must successfully navigate the path to market under the growing pressure of regulation and competition and while carefully managing technical and financial risk.

Qualification’s reduced set of testing requirements aims to demonstrate a method is suitable for its intended purpose, but it typically is not as robust as method validation.

We've really been looking forward to dropping this episode with Karen Harris, CFO and Head of Mission-Related Investing at the Alzheimer's Drug Discovery Foundation. While the markets have warmed a bit since we recorded this episode of the Business of Biotech, Karen's thoughtful perspective on the sometimes tumultuous Alzheimer's therapeutics space is valuable to any drug developer working in the cognitive medicines arena. Tune in!

By providing sensitive and accurate analytical data, analytics can help upstream development by performing spent media analysis or downstream purification by analyzing protein products.

With services to develop and scale up Probiotics, Postbiotics, and Microbial Therapeutics, explore how Sacco System’s capabilities can help take your drug product to market safely and efficiently.

Working with the right CDMO is vital for successful drug lifecycle management. We now serve more than half of the world’s leading biopharmaceutical companies, sharing their mission to expedite patient access to life-saving biologics.